gemtuzumab ozogamicin

gemtuzumab ozogamicin (MYLOTARG) is an FDA-listed pharmaceutical active ingredient. Associated with Pfizer Australia Pty Ltd. Route of administration: single-dose. Current US regulatory status: approved.

MYLOTARG is a marketed brand name for gemtuzumab ozogamicin. Check FDA Drugs@FDA for the current US label holder and prescribing information.

gemtuzumab ozogamicin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.